相关实验视频
Updated: Jul 8, 2026
12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
47.1K
基因斯坦:对IMR-32神经母细胞瘤细胞进行初步体外评估
Alina Heghes1, Alexandra-Denisa Semenescu1,2, Georgiana Moise3
1Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania.
Current health sciences journal
|November 20, 2025
概括
基因斯坦 (GEN) 显示出作为治疗神经母细胞瘤 (NB) 的天然化合物具有前途. 这项研究发现,GEN有效地降低了神经母细胞瘤细胞活力,并诱导了无损健康细胞的亡.
科学领域:
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
- 细胞生物学 细胞生物学
背景情况:
- 神经母细胞瘤 (NB) 是一种常见的儿童癌症,预后不佳.
- 现有的化疗因耐药性发展而面临挑战,突出显示了对新型治疗的需求.
研究的目的:
- 为了研究基因斯坦 (GEN) 作为潜在的治疗剂对人类神经母细胞瘤 (NB) 细胞 (IMR-32) 的体外疗效.
主要方法:
- 在体外评估基因斯坦对人类神经母细胞瘤IMR-32细胞和健康的HaCaT细胞的影响.
- 评估细胞活力,膜完整性 (LDH释放),细胞形态和核变化.
主要成果:
- 基因斯坦在50和75μM时对神经母细胞瘤细胞表现出显著的细胞毒性作用,降低了活力.
- 但GEN并没有影响健康的HaCaT细胞的活力.
- 热尼斯坦诱导了细胞膜降解,改变了细胞形状,并引起了核变化,表明了细胞亡.
结论:
- 基因斯坦在体外证明了对神经母细胞瘤的治疗潜力.
- 像基因斯坦这样的天然化合物为神经母细胞瘤治疗开发提供了有前途的新途径.
相关概念视频
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.